Toggle navigation
Home
Search
Services
Blog
Contact
About
Cellular-Harvey-Ras Activation During Cisplatin-Initiate
Nelson, Mark A.
University of Arizona, Tucson, AZ, United States
Search 173 grants from Mark Nelson
Search grants from University of Arizona
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A Randomized Controlled Trial of Women Involved in Supporting Health (WISH), a Peer-Led Intervention to Improve Postpartum Retention in HIV Care
Liver Cancer (LC) (Project-003)
Role of TRIM79 in innate immunity to tick-borne encephalitis virus
Transgenic Anaylsis of Retinal Development
Iga Protease and Dental Caries
Recently added grants:
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections
Role of HOS in Cell Transformation and Apoptosis
Statistical Methods for Evaluating Markers for Treatment Selection
Determinants of T Cell Fate in Transplantation Tolerance
Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32ES005533-01
Application #
3038333
Study Section
Immunology, Virology, and Pathology Study Section (IVP)
Project Start
1991-07-31
Project End
Budget Start
1991-02-01
Budget End
1992-01-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
University of Arizona
Department
Type
Schools of Medicine
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Related projects
NIH 1992
F32 ES
Cellular-Harvey-Ras Activation During Cisplatin-Initiate
Nelson, Mark A. / University of Arizona
NIH 1991
F32 ES
Cellular-Harvey-Ras Activation During Cisplatin-Initiate
Nelson, Mark A. / University of Arizona
Comments
Be the first to comment on Mark Nelson's grant